Daihan Pharmaceutical Co.Ltd (023910) — Financial Flexibility Index
Daihan Pharmaceutical Co.Ltd (023910) has a Financial Flexibility Index of 0.40x as of September 2025. Free cash flow of ₩20.27 Billion (operating CF ₩9.47 Billion minus capex ₩10.79 Billion) represents 0% of total liabilities (₩50.75 Billion). Check 023910 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Daihan Pharmaceutical Co.Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Daihan Pharmaceutical Co.Ltd across 11 annual periods. See 023910 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Daihan Pharmaceutical Co.Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for Daihan Pharmaceutical Co.Ltd. For the full company profile including market capitalisation, see Daihan Pharmaceutical Co.Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.06x | ₩51.44 Billion | ₩35.64 Billion | ₩48.42 Billion | ▼ -18.2% |
| 2023 | 1.30x | ₩60.14 Billion | ₩38.86 Billion | ₩46.28 Billion | ▲ +78.2% |
| 2022 | 0.73x | ₩37.62 Billion | ₩29.00 Billion | ₩51.58 Billion | ▼ -3.1% |
| 2021 | 0.75x | ₩52.47 Billion | ₩40.62 Billion | ₩69.73 Billion | ▲ +37.3% |
| 2020 | 0.55x | ₩38.99 Billion | ₩33.63 Billion | ₩71.17 Billion | ▼ -16.5% |
| 2019 | 0.66x | ₩52.57 Billion | ₩35.26 Billion | ₩80.08 Billion | ▼ -32.4% |
| 2018 | 0.97x | ₩91.63 Billion | ₩44.94 Billion | ₩94.39 Billion | ▲ +60.3% |
| 2017 | 0.61x | ₩41.50 Billion | ₩20.45 Billion | ₩68.52 Billion | ▼ -18.1% |
| 2016 | 0.74x | ₩49.82 Billion | ₩27.92 Billion | ₩67.36 Billion | ▲ +109.0% |
| 2015 | 0.35x | ₩21.94 Billion | ₩17.98 Billion | ₩61.99 Billion | ▲ +19.7% |
| 2014 | 0.30x | ₩19.95 Billion | ₩9.48 Billion | ₩67.52 Billion | — |